Table 5.
Resistant isolates of different antimicrobial agents over the 2 periods.
| Resistant isolates | ||||
|---|---|---|---|---|
| Period 1 n (%) | Period 2 n (%) | Total n (%) | P | |
|
| ||||
| Oral cefuroxime n=126 | - | 48 (36.4) | 48 (23.0) | .0001 |
| Parental cefuroxime n=137 | 8 (10.5) | 64 (48.5) | 72 (34.5) | .0001 |
| Cefotaxime/ceftriaxone Nonmeningeal n=204 | 0 (.0) | 4 (3.1) | 4 (1.9) | .455 |
| Cefotaxime/ceftriaxone Meningeal n=188 | 16 (21.1) | 23 (17.4) | 39 (18.8) | .543 |
| Meropenem n=195 | 4 (5.2) | 5 (3.8) | 9 (4.3) | .771 |
| Vancomycin n=197 | 0 (.0) | 0 (.0) | 0 (.0) | |
| Erythromycin n=144 | 12 (15.8) | 62 (47) | 74 (35.5) | .0001 |
| SXT n=143 | 15 (19.7) | 93 (70.5) | 108 (51.9) | .0001 |